Blog

  • Is a Universal Coronavirus Vaccine in Our Future?

    Is a Universal Coronavirus Vaccine in Our Future?

    Read Article
  • 3 Red Flags That Could Indicate Telehealth Fraud, Waste and Abuse

    3 Red Flags That Could Indicate Telehealth Fraud, Waste and Abuse

    Read Article
  • Beyond Buzzwords: Population Health Management & Spatiotemporal Analysis

    Beyond Buzzwords: Population Health Management & Spatiotemporal Analysis

    Did you know space-time data analysis can improve health outcomes while reducing costs? We explain what this all means and how we’re using spatiotemporal techniques to move healthcare forward.

    Read Article
  • How Population Health Management Can Help State Budgets & Public Health In Crisis

    How Population Health Management Can Help State Budgets & Public Health In Crisis

    Read Article
  • Fraud-Proof Your Telehealth Strategy for the New Healthcare Normal

    Fraud-Proof Your Telehealth Strategy for the New Healthcare Normal

    Read Article
  • Health Outreach Consumers Want & Need: Adopting a More-Is-More Approach to Health Engagement

    Health Outreach Consumers Want & Need: Adopting a More-Is-More Approach to Health Engagement

    Read Article
  • Using Episodes of Care Reviews To Follow the Patient Journey

    Using Episodes of Care Reviews To Follow the Patient Journey

    Read Article
  • As Payment Accuracy Shifts To a Member-Centric Approach, Recovery of Overpayments Accelerates

    As Payment Accuracy Shifts To a Member-Centric Approach, Recovery of Overpayments Accelerates

    Read Article
  • Advancing Drug Development During the Pandemic: Challenges & Opportunities

    Advancing Drug Development During the Pandemic: Challenges & Opportunities

    Read Article
  • Consumer Engagement: The Key To Mitigating the Pandemic’s Secondary Health Crises

    Consumer Engagement: The Key To Mitigating the Pandemic’s Secondary Health Crises

    Read Article
  • 3 Ways To Strengthen Program Integrity Around Prescription Drug Coverage

    3 Ways To Strengthen Program Integrity Around Prescription Drug Coverage

    In this blog post, we'll examine three program integrity best practices for controlling prescription drug costs, including special considerations in light of COVID-19.

    Read Article
  •  Increasing Breast Cancer Screening for Women

    Increasing Breast Cancer Screening for Women

    On average, only 55% of the women who should get mammograms actually do. More work remains to engage and educate women to get timely breast cancer screenings.

    Read Article
  • Modernize Your Program Integrity Operations With These 6 Audit Efficiencies

    Modernize Your Program Integrity Operations With These 6 Audit Efficiencies

    Read Article
  • Bridging the Telehealth Education Gap for Medicare Members

    Bridging the Telehealth Education Gap for Medicare Members

    Read Article
  • The Cost of Racial Inequity in Healthcare

    The Cost of Racial Inequity in Healthcare

    Read Article
  • 5 Potential Sources of COVID-19-Related Fraud, Waste & Abuse

    5 Potential Sources of COVID-19-Related Fraud, Waste & Abuse

    In our latest blog, we highlight five potential sources of fraud, waste and abuse that may stem from the COVID-19 crisis.

    Read Article
  • How COVID-19 Is Transforming the Regulatory Landscape

    How COVID-19 Is Transforming the Regulatory Landscape

    Read Article
  • Subrogation & Healthcare Claims: Is Your Plan Leaving Money on the Table?

    Subrogation & Healthcare Claims: Is Your Plan Leaving Money on the Table?

    If your health plan isn’t using subrogation to recover medical costs that another party is responsible for, you may be leaving money on the table.

    Read Article
  • A State’s Guide to Program Integrity in a Pandemic

    A State’s Guide to Program Integrity in a Pandemic

    Read Article
  • Beyond Buzzwords: Anomaly Detection in Machine Learning

    Beyond Buzzwords: Anomaly Detection in Machine Learning

    Read Article
  • loading
    Loading More...